Previous issue | Volume 92 | ESPE2019

58th Annual ESPE meeting

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

Card image cap
The theme of this year’s meeting is Variety and Variation in Paediatric Endocrinology. Join us in Vienna to explore the diversity we encounter in our discipline and the care that we have to exercise when using the term “normality”. Whilst gaining an update on the latest treatments, clinical best practice and cutting edge research in the field of paediatric endocrinology.

RFC - Late Breaking

Late Breaking Abstracts

BMP4 Mutations as a Novel Cause of Normosmic Hypogonadotropic Hypogonadism
1University of Mississippi Medical Center, Jackson, MS, USA. 2Diyarbakir Pediatric Hospital, Diyarbakir, Turkey. 3Cukurova University, Faculty of Medicine, Adana, Turkey. 4Antakya State Hospital, Antakya, Turkey. 5Dicle University, Faculty of Medicine, Diyarbakir, Turkey. 6Sanliurfa Training and Research Hospital, Sanliurfa, Turkey
hrp0092rfc15.2
Metformin Treatment Affects ACTH Receptor Activation and Downstream Signaling: A Potential Treatment for ACTH Excess Disorders and Management of Hyperandrogenic States
1University Children's Hospital, Bern, Switzerland. 2Department of Biomedical Research(DBMR), University of Bern, Bern, Switzerland
hrp0092rfc15.3
Clinical and Genetic Characterization of 148 Patients with Persistent or Transient Congenital Hyperinsulinism: A Population-Based Study in Finns
1Department of Pediatrics, University of Eastern Finland, Kuopio, Finland. 2Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland. 3Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland. 4Children's Hospital, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland. 5Research Programs Unit, Molecular Neurology and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 6Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, and Kuopio University Hospital, Kuopio, Finland
hrp0092rfc15.4
De novo Missense Mutation in SP7 in a Patient with Cranial Hyperostosis, Long Bone Fragility, and Increased Osteoblast Number
1University Clinic of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. 2Section on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, USA. 3Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria. 4Department of Pediatrics, Hospital of Braunau, Braunau, Austria. 5Orthopedic Department, Medical University of Innsbruck, Innsbruck, Austria. 6Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria. 7Division of Clinical Biotechnology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 8Genetic Engineering Core, National Eye Institute, National Institutes of Health, Bethesda, USA
hrp0092rfc15.5
Absence of Puberty and Estrogen Resistance by Estrogen Alpha Receptor Inactivation in Two Sisters: A Mutation for Variable Phenotypic Severity
1Université de Paris, INSERM U1141, Paris, France. 2National Center for Diabetes, Endocrinology and Genetics/ The University of Jordan, Amman, Jordan. 3Université de Paris, INSERM IAME UMR 1137, paris, France. 4Laboratoire Biochimie-Hormonologie, Hôpital Robert Debré, Paris, France. 5Laboratoire Biochimie-Hormonologie, Hôpital Robert Debré, paris, France
hrp0092rfc15.6